Kahlert Institute for Addiction Medicine Adopts MedMinder’s Smart Adherence Platform to Enhance Patient Care and Recovery Outcomes
Strategic collaboration establishes Kahlert Institute for Addiction Medicine as the newest client of MedMinder Systems Inc., integrating cutting-edge medication adherence technology into addiction treatment programs.
- (1888PressRelease) May 16, 2025 - Norwood, MA – MedMinder Systems Inc., the leading provider of connected medication adherence solutions, proudly announces the Kahlert Institute for Addiction Medicine as its newest client partner. Based within the University of Maryland School of Medicine, the Kahlert Institute for Addiction Medicine is nationally recognized for its integrative approach to addiction medicine.
As part of this collaboration, the Kahlert Institute for Addiction Medicine has officially adopted MedMinder’s smart medication management platform as a critical component of a clinical trial examining methods to treat pain in persons who have addiction. Embedding the MedMinder into routine clinical operations provides researchers a unique opportunity to examine how medication dosing parameters may be leveraged to help patients.
“We are excited to welcome the Kahlert Institute for Addiction Medicine as a MedMinder partner,” said Troy Hilsenroth, CEO of MedMinder Systems Inc. “Its adoption of our platform reflects growing recognition that digital adherence tools can drive meaningful improvements in addiction care. This collaboration allows us to demonstrate the power of smart, data-driven solutions in a real-world, high-impact setting.”
The MedMinder device offers a comprehensive suite of features, including real-time adherence monitoring, automated reminders, built-in video calling, and precision data analytics. These tools are designed to increase patient accountability, facilitate early interventions, and empower both caregivers and clinical teams with actionable insights. The device’s user-friendly design also supports implementation across diverse care environments, from outpatient programs to patients' homes.
The Kahlert Institute for Addiction Medicine unites neuroscience, behavioral science and clinical practice to address addiction from bench to bedside. This new engagement underscores MedMinder’s growing role as a preferred technology partner in behavioral health and reinforces its commitment to supporting patient-centric, outcomes-driven care through innovation.
About MedMinder Systems Inc.
MedMinder is redefining medication management through its connected pharmacy and smart adherence platform, helping to close critical gaps in care for patients managing chronic conditions, behavioral health challenges, and complex treatment regimens. With features like real-time monitoring, built-in video communication, and data-rich insights, MedMinder enables safer, more effective medication adherence at scale. From home settings to clinical programs, MedMinder’s assistive technology is supporting healthcare systems nationwide in delivering personalized, proactive care.
About the Kahlert Institute for Addiction Medicine
Established with funding from the Kahlert Foundation, University of Maryland, Baltimore, and the University of Maryland School of Medicine, the Kahlert Institute leads a national effort to transform addiction care. By uniting neuroscientists, clinical experts, and physician educators, the Institute develops solutions that fuel the journey from discovery to recovery and train a new generation of leaders in addiction medicine.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam